Inventor
ATASSI M ZOUHAIR
US16 patents
⚠️ This page may combine multiple inventors who share the name “ATASSI M ZOUHAIR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ALLERGAN INC
9 patentsUS7341843B2Mar 11, 2008
Botulinum toxin A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
ALLERGAN INC48 citations95
US7531179B2May 12, 2009
BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
ALLERGAN INC11 citations92
US7691587B2Apr 6, 2010
Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides
ALLERGAN INC8 citations83
US7462699B2Dec 9, 2008
BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
ALLERGAN INC11 citations83
US7855268B2Dec 21, 2010
Tolerogizing compositions comprising botulinum toxin type B peptides
ALLERGAN INC5 citations73
US7670788B2Mar 2, 2010
Determining and reducing immunoresistance to a Botulinum toxin therapy using Botulinum toxin B peptides
ALLERGAN INC6 citations73
US7635484B2Dec 22, 2009
BoNT/A peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy
ALLERGAN INC5 citations73
US7968304B2Jun 28, 2011
Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides
ALLERGAN INC1 citations62
US7972801B2Jul 5, 2011
Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin B peptides
ALLERGAN INC1 citations51
(unassigned)
3 patentsUS6048529AApr 11, 2000
PVA or PEG conjugates of peptides for epitope-specific immunosuppression
46 citations91
US5861477AJan 19, 1999
Cyclic peptide catalysts modeled on enzyme active sites
1 citations51
US5759834AJun 2, 1998
Synthetic sterically-constrained pepzyme catalysts modeled on lysozyme and ribonuclease
1 citations51
ATASSI M ZOUHAIR
2 patentsUS8236513B2Aug 7, 2012
Determining and reducing immunoresistance to botulinum toxin therapy using botulinum toxin A peptides
ATASSI M ZOUHAIR3 citations59
US8137675B2Mar 20, 2012
Bont/a peptides and methodsof predicting and reducing immunoresistance to botulinum toxin therapy
ATASSI M ZOUHAIR1 citations59